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Background. Human Natural killer (NK) cells are characterized by NK cell recep-
tors (NKRs) with inhibitory and activatory function that fi nely control their func-
tional activities. In particular, they express inhibitory receptors for MHC class I mol-
ecules, named killer cell immunoglobulin (Ig)-like receptors (KIRs) and C-type lectin 
CD94-CD159a, and many triggering molecules like NKp30, NKp44, NKp46, (called 
natural cytotoxicity receptors, NCRs), NKG2D, CD161, and CD244. The majority of 
peripheral blood human NK cells are characterized by a phenotype with a low den-
sity expression of CD56 (CD56dim) and a high expression of CD16 (CD16bright), where-
as a minority (approximately 5–10%) shows a bright expression of CD56 (CD56bright). 
This latter NK subset presents relatively high expression of some cytokine recep-
tors (CD117 and CD25) and the CD94-CD159a heterodimeric inhibitory receptor. 
CD56bright NK cells are widely expressed in lymphoid tissues and can be generated 
from CD34+ cells when cultured with combinations of ﬂ t-3 ligand (FL) or stem cell 
factor plus IL-15 or IL-2. During their development, NK cells sequentially acquire 
many diff erent antigens but there is still limited knowledge on diff erentiation anti-
gens able to identify immature human NK cells and the specifi c sequence through 
which developing NK cells acquire the expression of NKR.
Methods. NK cells obtained from human CD34+ hematopoietic progenitor cells 
after 30-day culture with FL plus IL-15, or from peripheral and umbilical cord blood 
samples were characterized.
Results. Virtually, all CD56 NK cells diff erentiated in vitro expressed CD117, CD25, 
NCRs, NKG2D, CD161, and CD244, while only a subset expressed CD18-CD11a 
(LFA-1), and CD94 molecule, defi ning an immature CD56bright/NCRs+/NKG2D+/
LFA-1-/CD94- subset. Another small subset of cells expressing CD94 but not LFA-1 
integrin was also identifi ed, suggesting that during NK diff erentiation LFA-1 might 
be upregulated later than CD94. To verify this hypothesis in vivo, we evaluated the 
NK cell expression of LFA-1 in both peripheral and umbilical cord blood samples. 
Interestingly, in these blood ﬂ uids, we have identifi ed a lineage negative CD34-/LFA-
1low/NKp46dim/NKG2Ddim/CD94- subset that resembled an immature stage of NK 
cells present in lymph nodes.
Conclusions. Altogether, the results indicate that CD18-CD11a integrin, as well as 
CD11b in mice, may be a useful marker to identify immature stages of human NK 
cell diff erentiation.
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